Progression of colorectal cancer (CRC) involves spatial and temporal occurrences of epithelial-mesenchymal transition (EMT), whereby tumour cells acquire a more invasive and metastatic phenotype. Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours. Importantly, initiation of tumour growth at the secondary site is the rate-limiting step in metastasis. However, investigation of this dynamic reversible EMT and MET that underpins CRC morphogenesis has been hindered by a lack of suitable in vitro models. To this end, we have established a unique in vitro model of CRC morphogenesis, which we term LIM1863-Mph (morphogenetic). LIM1863-Mph cells spontaneously undergo cyclic transitions between two-dimensional monolayer (migratory, mesenchymal) and three-dimensional sphere (carcinoid, epithelial) states. Using RNAi, we demonstrate that FZD7 is necessary for MET of the monolayer cells as loss of FZD7 results in the persistence of a mesenchymal state (increased SNAI2/decreased E-cadherin). Moreover, FZD7 is also required for migration of the LIM1863-Mph monolayer cells. During development, FZD7 orchestrates either migratory or epithelialization events depending on the context. Our findings strongly implicate similar functional diversity for FZD7 during CRC morphogenesis.
Introduction
Frizzled-7 (FZD7) is a seven-pass trans-membrane Wnt receptor that governs developmental morphogenetic events such as gastrulation (Winklbauer et al., 2001; Tada et al., 2002) . Gastrulation is a series of coordinated movements of cell groups to establish the basic body plan of vertebrate embryos and as such involves remarkable changes in cell morphology, cell adhesion, cell-cell junction and cell mobility. Although colorectal carcinoma (CRC) morphogenesis shares similarities with this developmental morphogenetic process (Kirchner and Brabletz, 2000) , and FZD7 is frequently overexpressed in CRC (reviewed in (Vincan, 2004) ) FZD7 function has not been investigated in the context of CRC morphogenesis.
Several lines of evidence support a role for FZD7 in CRC morphogenesis. FZD7 is the sole FZD family member conserved through evolution from Hydra to man in developing gut systems, consistent with a role in establishing three-dimensional (3-D) gut epithelial tissue architecture (Sagara et al., 1998; Minobe et al., 2000) . In addition, FZD7 orchestrates several developmental morphogenetic events leading to both construction (epithelial organization of somites; Linker et al., 2005) and de-construction (neural crest cell migration; De Calisto et al., 2005) of 3-D epithelial tissue architecture. It orchestrates these opposing processes by activating different Wnt/FZD signalling pathways (reviewed in Vincan, 2004) . As for all FZD family members, FZD7-mediated activation of canonical Wnt signalling (Logan and Nusse, 2004) leads to expression of b-catenin/TCF/ LEF target genes whereas activation of non-canonical Wnt signalling (Tada et al., 2002; Veeman et al., 2003) is associated with morphogenetic movement.
At a molecular level, activation of the canonical pathway inhibits the enzyme activity of the serine threonine kinase GSK-3b. GSK-3b is part of a destruction complex, which also includes the Adenopolyposis Coli (APC) protein and Axin, that regulates the cytoplasmic and nuclear levels of b-catenin (Logan and Nusse, 2004) . Vertebrate non-canonical pathways instead regulate the activity of Rock and JNK, and/or the Ca 2 þ -sensitive kinases, PKC and CamKII (Veeman et al., 2003) . The Wnt/FZD signalling pathway activated by FZD7 during a particular developmental process is likely to be influenced by co-expressed Wnts and FZDs, and the cellular and tissue context. Functionally, FZD7 affects cellular processes such as cell differentiation, adhesion and motility, processes that are now considered central to epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET), and consequently tumour growth and progression.
Although there are differences between EMT and MET during normal development and cancer, many parallels have been drawn between the observations and molecular description of EMT and MET in developmental tissues, and cancer cell trans-differentiation events in the adult (Thiery, 2002; Thiery and Sleeman, 2006) . For instance, EMT in cancer, as in development, is associated with a decrease in cell proliferation (Brabletz et al., 2001; Barrallo-Gimeno and Nieto, 2005) . Furthermore, the epithelial phenotype appears to be a 'default' phenotype and a transition from this to a mesenchymal state requires both the repression of epithelial genes and induction of mesenchymal genes (Frisch, 1997; Barrallo-Gimeno and Nieto, 2005) . This is achieved, at least in part, through activation of transcriptional factors known to induce EMT. Interestingly, whereas tumour cells undergo an EMT-like change allowing them to migrate away from the primary tumour, most CRC metastases recapitulate the differentiation status of the primary tumour (Brabletz et al., 2001 (Brabletz et al., , 2005 . Disseminated tumour cells with mesenchymal characteristics are thought to revert back to epithelial morphology in order to re-instate cell proliferation and initiate tumour growth at the secondary site (Brabletz et al., 2001; Thiery, 2002) . Importantly, initiation of tumour growth at the secondary site is the rate-limiting step to metastasis (Chambers et al., 2002) , thus the ability to block this step offers novel avenues for cancer therapy.
Our previous studies (Vincan et al., 2005) show that stable expression of a FZD7 receptor ectodomain in a moderately differentiated CRC cell line that grows in two-dimension (2-D) induces a partial EMT and also dramatically attenuates xenograft tumour growth. As FZD receptor ectodomains generally inhibit FZD signalling, these findings implicate FZD7 in the converse phenotype transition MET, and in the establishment of 3-D tumour tissue architecture. To test this possibility directly, we examined the role of FZD7 in MET and 3-D organization of tumour cells. We employ a unique CRC morphogenesis culture system that we have established by adapting the human CRC cell line LIM1863 that grows as 3-D spheres (Whitehead et al., 1987) . We demonstrate that this adapted cell line, which we refer to as LIM1863-Mph (morphogenetic), faithfully recapitulates the dynamic phenotype transitions, characteristic of the human disease state. Moreover, we demonstrate that FZD7 is required for these dynamic phenotype transitions. Our data establish a molecular mechanism whereby FZD7 facilitates tumour morphogenesis and provide evidence of a functional link between the upstream components of the Wnt/FZD signalling pathway and CRC progression.
Results

Adapted LIM1863-Mph cells model CRC morphogenesis
The human CRC cell line LIM1863 (Whitehead et al., 1987) forms free-floating multicellular spheres where highly polarized cells are arranged around a central lumen (Figure 1a) . The spheres contain morphologically differentiated columnar and goblet cells (Figure 1a) , the two main cell types found in colonic crypts, and thus resemble enclosed colonic crypts (referred to as organoids (organ-like) by Whitehead et al., 1987) (Hayward and Whitehead, 1992 ) and the cell line forms carcinoma xenografts (Whitehead et al., 1987) . Consequently the 3-D structures also closely resemble enclosed carcinoma tubules and thus we refer to them as carcinoids (carcinoma-like). Notably, b-catenin was predominantly membrane bound in these polarized epithelial cells (Figure 1a) . Although adjacent cells in the free-floating carcinoids are tightly associated with each other through cell-cell junctions (Whitehead et al., 1987) , the occasional carcinoid spontaneously anchored to the tissue culture plastic and formed an adherent monolayer patch (Figure 1b) . This was an infrequent event but by enriching for the monolayer patches we adapted the LIM1863 cells to promote this property so that monolayer formation, which bares the morphological hallmarks of EMT, was efficient. To adapt the cell line, approximately two-thirds of the spent culture medium (including free-floating carcinoids) was aspirated and the cultures replenished with fresh medium. Once monolayer patch formation was efficient, the adapted phenotype was maintained over several weeks. EMT of the carcinoids was reversible; the monolayer cells subsequently spontaneously trans-differentiated into polarized/differentiated cells that again assembled freefloating carcinoids. Beginning at the centre of monolayer patches, morphologically the cells underwent an MET (Figure 1b) . Time lapse imaging revealed that spontaneous EMT, MET and generation of free-floating carcinoids took 3-4 days and was a continuous cyclic process that did not require added cytokines and presumably involved dynamic re-modelling of cell-cell contact and cell adhesion mediated by localized release of endogenous factors (Figure 1c , Supplementary movie 1). Moreover, time-lapse imaging revealed that the monolayer cells migrate on the tissue culture plastic as an epithelial sheet (Figure 1d , Supplementary movie 2). To distinguish these adapted cells from the parental cell line, which have been minimally passage in medium with additional supplements since their isolation (Whitehead et al., 1987) , and from LIM1863 cells that have been propagated by continuous passage as non-adherent carcinoids in medium supplemented with fetal calf serum (FCS) alone, we refer to the adapted cell line as LIM1863-Mph (morphogenic).
We next analysed the expression pattern of markers of EMT and MET during this dynamic process. Trypsindissociated monolayer cells were seeded at low density to form monolayer patches (see Materials and methods). This essentially synchronizes subsequent MET and carcinoid assembly. Total RNA was prepared from monolayer cells (EMT), early-MET (cells beginning to re-organize at the centre of patches), MET, late-MET (carcinoids starting to bud from the monolayer) and free-floating carcinoids. The expression patterns of selected markers relevant to CRC EMT were quantified by real-time reverse transcription-polymerase chain reaction (RT-PCR) (Figure 2 ). E-cadherin expression was maintained throughout this dynamic process with a modest increase in E-cadherin in early MET relative to EMT. The sustained expression of E-cadherin indicates that this EMT was incomplete and that cell-cell contact of monolayer cells (Figure 1b ** ** ** ** Figure 2 The spontaneous EMT of LIM1863-Mph carcinoid cells was incomplete. Expression of E-cadherin, SNAI2, SNAI1, laminin-5 a3 and g2 subunits (Lama3 and Lamg2, respectively) and MMP7 was quantified by real-time PCR on cDNA samples prepared from the indicated cell populations during the course of transition from monolayer patch (EMT) to free-floating carcinoid. Some E-cadherin expression was maintained throughout the transition, whereas SNAI2, laminin-5 and MMP7 were markedly increased in the monolayer LIM1863-Mph cells compared to carcinoids (data are mean7s.e.m., **Pp0.005; ND, not detected).
FZD7 and colorectal cancer morphogenesis E Vincan et al snail), SNAI2 (formerly slug), (SIP-1 and ZEB)), the expression pattern of SNAI2 was consistent with cell morphology transitions, which suggests its involvement in this EMT process. SNAI2 expression was highest in the EMT cells. This expression decreased during the various stages of MET to undetectable levels in the freefloating carcinoids (Figure 2 ). In contrast, the expression pattern of the other EMT-inducing transcription factors did not parallel the morphological transitions observed (SNAI1 ( Figure 2 ); ZEB and SIP-1, data not shown).
Notably, as recorded with other tumour cell lines (Cano et al., 2000) , LIM1863-Mph cells co-express abundant E-cadherin and SNAI1. Expression of the laminin-5 chains a3 and g2, and the metalloproteinase MMP7 was markedly increased during transition from freefloating carcinoid to monolayer cells. Collectively, these data demonstrate that the EMT of carcinoid cells is molecularly defined by a trend towards decreased E-cadherin and increased SNAI2, laminin-5 and MMP7 expression. Analysis of LIM1863-Mph adherens junction proteins by immunofluorescence confocal microscopy confirmed that the spontaneous EMT was incomplete. Although E-cadherin was reduced at the leading edge of cells, it was maintained at cell-cell contacts ( Figure 3a) . Consistent with this, b-catenin expression ( Figure 3b ) was also decreased at the leading edge of migrating cells but maintained at sites of cell-cell contact. Time-lapse imaging revealed that cell-cell contact also remained intact during cell migration so that the monolayer LIM1863-Mph cells migrated as an epithelial sheet ( Figure 1d , Supplementary movie 2).
The subcellular localization of b-catenin was dynamically regulated during transition between monolayer and carcinoid. As stated above, b-catenin was membrane-bound in the polarized carcinoid cells ( Figure 1a ). Some nuclear b-catenin was detected in the monolayer LIM1863-Mph cells (Figure 3c ). However, the intense nuclear b-catenin detected in the cells lifting off the tissue culture plastic (Figure 3d ) suggested that canonical Wnt/FZD signalling was dramatically upregulated during MET and initiation of carcinoid assembly. Consistent with this observation, carcinoid assembly continued efficiently in the presence of LiCl, an inhibitor of GSK3b that mimics activation of canonical signalling ( Figure 4 , see below).
In agreement with the associated shut down in proliferation associated with EMT during development and in CRC (Brabletz et al., 2001) , EMT of LIM1863-Mph was paralleled by decreased cell proliferation (Ki-67 staining; Figure 3f and h). As the cells separated at the centre of the monolayer patches and lifted off the tissue culture plastic to assemble carcinoids, cell proliferation was re-instated ( Figure 3g ) and all the nuclei in the carcinoids stained intensely with Ki-67 ( Figure 3i ; Supplementary movie 3; Figure 3j shows a projection of Z-section-6 (Figure 3h ) to -14 (Figure 3i) ). These observations with immunofluorescence confocal microscopy were confirmed with cell proliferation studies using incorporation of [ 3 H]-thymidine. Assembly of carcinoids was associated with cell proliferation and was inhibited in the presence of the DNA synthesis inhibitor mitomycin-C. As anticipated, monolayer cells were resistant to mitomycin-C and remained viable without proliferation (Figure 4a and b). Carcinoid assembly and cell proliferation were decreased after treatment with transforming growth factor (TGF) b, a cytokine known to induce EMT of LIM1863 cells (Hayward et al., 1995; Bates and Mercurio, 2003) , but was not inhibited by treatment with LiCl ( Figure 4a and b). LiCl mimics canonical Wnt signalling (Kao and Elinson, 1998) , which we confirmed here in the context of LIM1863-Mph using the b-catenin/TCF transcription reporter TOPflash (Korinek et al., 1997) (Figure 4c ).
Effect of FZD7 loss in LIM1863-Mph
Generation of carcinoids appeared to require MET (Figures 1-3) , and as our previous findings in a 2-D Ki-67 Figure 3 Phenotypic analysis of LIM1863-Mph revealed that MET was associated with nuclear b-catenin and increased cell proliferation. Immunofluorescence and confocal laser scanning microscopy showed that membranous E-cadherin (a) and b-catenin (b) were decreased at the leading edge of monolayer cells (short arrows), although their expression was maintained at cell-cell junctions (arrowheads). Some nuclear b-catenin (c) was seen in the EMT monolayer cells, whereas intense nuclear b-catenin (d) was evident in cells rising off the plastic to assemble carcinoids (MET, long arrows). Cell proliferation (Ki-67 staining) was low in monolayer LIM1863-Mph cells (f, h) but as the cells transdifferentiated to assemble carcinoids, cell proliferation was reinstated (g) so that nuclei in the carcinoid stained intensely for Ki-67 (i); (j) is a projection of Z-sections 6-14; (e) staining with control Ab. Shown are the indicated single confocal Z-sections (f-i) or projections of several Z-sections (a-e, j) (scale bars ¼ 50 mm).
colorectal cell line implicate FZD7 in MET and establishment of 3-D tumour tissue architecture (Vincan et al., 2005) , we investigated the role of FZD7 in LIM1863-Mph carcinoid assembly using RNAi. We employed a retroviral-based gene transfer strategy to introduce RNAi into monolayer LIM1863-Mph cells. Monolayer cells were infected with FZD7 targeting RNAi retrovirus (short-hairpin (sh) RNA, shFZD7), selected with puromycin and the effects of FZD7 depletion on carcinoid assembly was assessed. Decreasing endogenous FZD7 message in LIM1863-Mph cells with shFZD7 was confirmed by quantitative real-time RT-PCR (Figure 5a ). Decreasing FZD7 expression in monolayer LIM1863-Mph with shFZD7 abrogated carcinoid assembly (Figure 5b ). In contrast, carcinoid generation was unaffected in control transduced (shCont) LIM1863-Mph. The LIM1863-Mph-shFZD7 cells looked healthy, were metabolically active and could be maintained in culture by replenishing the spent culture medium. The morphology of the cells suggested that the cells could not undergo MET when FZD7 expression was decreased (Figure 4b ). Indeed, FZD7 loss resulted in a modest increase in SNAI2 and a concomitant decrease in E-cadherin expression, which are characteristics of EMT in these cells, indicating persistence of the mesenchymal phenotype in shFZD7-transduced LIM1863-Mph (Figure 4c) . Expression of SNAI1, SIP-1 or ZEB1 (Supplementary Figure 1) , other transcriptional factors also known to induce EMT and repress E-cadherin in certain contexts (Barrallo-Gimeno and Nieto, 2005), was not increased in shFZD7-transduced LIM1863-Mph. However, in stark contrast to EMT LIM1863-Mph cells (Figure 2 ), LIM1863-MphshFZD7 cells did not express increased laminin-5 a3 and g2 chains (Figure 5c ). Moreover, the LIM1863-MphshFZD7 cells did not migrate on the tissue culture plastic (Figure 5d ). Similar molecular changes were observed with shFZD7 in an independent CRC cell line SW480 (Supplementary Figure 2) .
In addition to a mesenchymal appearance, proliferation in the LIM1863-Mph-shFZD7 cells appeared to be reduced. Thus, we next assessed the effects of shFZD7 on cell proliferation. The dramatic increase in Ki-67 staining typically associated with MET of LIM1863-Mph cells (Figure 3g ) was not observed in shFZD7-transduced LIM1863-Mph cells (Figure 6a ). Furthermore, b-catenin localization in the LIM1863-Mph-shFZD7 (Figure 6a ) was characteristic of EMT LIM1863-Mph (Figure 3b and c), with a distinct absence of the intense nuclear staining recorded during MET (Figure 3d ). To independently quantify the effect on cell proliferation, we measured DNA synthesis relative to cell number (to control for variations in cell number after puromycin selection) and showed that this ratio was significantly less (Pp0.02, n ¼ 3) in the LIM1863-Mph-shFZD7 cells (Figure 6b , and serum-starved HEK293T cells, Supplementary Figure 3) . Similarly transduction of an independent CRC cell line SW480, which normally expresses abundant FZD7 mRNA ( Supplementary Figures 2 and 4) , with shFZD7 retrovirus also decreased cell proliferation. In contrast, proliferation of SW620, a CRC cell line with low to undetectable FZD7 mRNA (Supplementary Figure 4) , was unaffected by shFZD7 (data not shown).
Collectively, these data support a block in MET and subsequent carcinoid assembly when FZD7 mRNA is depleted in LIM1863-Mph. Consistent with a requirement of FZD7 for MET and establishment of 3-D carcinoid architecture, we showed that transduction of anchored, mature carcinoids (see Materials and methods) with shFZD7 retrovirus did not affect carcinoid dispersal or formation of monolayer patches; however, subsequent generation of carcinoids from these monolayer patches was halted in the shFZD7-transduced LIM1863-Mph cells (Figure 7a) . Thus, transduction with shFZD7 did not affect EMT of the carcinoids whereas subsequent re-assembly (MET) of carcinoids was impeded. A diagrammatic representation of carcinoid morphogenesis and the roles indicated for FZD7 by the present study are shown in Figure 7b 
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however, localization of FZD7 in the carcinoma tissues has not been determined. As an extension to these expression studies performed on whole-tissue samples, we determined the localization of FZD7 protein in carcinoma tissues using immunohistochemistry. We analysed nine carcinoma tissues and identified invasive areas in most samples (7/9, one example is shown in Figure 8 ). As we have extensively described previously (reviewed in Brabletz et al., 2005) , tumour cells in central areas of carcinomas were well differentiated, forming extensive tubular structures. In contrast, this tubular organization was disrupted at the invasive front where de-differentiated tumour cells were interspersed with the stroma (Figure 8a ). Well-differentiated tumour cells engaged in tubular structures were actively proliferating (Ki-67 staining) and b-catenin in these cells was primarily membrane-bound. De-differentiation or EMT of the tumour cells at the invasive front was associated with increased b-catenin expression (both cytoplasmic and nuclear) and decreased cell proliferation (Ki-67 staining, Figure 8a ). In each carcinoma tissue where an invasive front was identified (7/7), FZD7 protein was predominantly expressed in the cytoplasm and at the plasma membrane of the well-differentiated CRC tumour cells present in central regions of the tumour (Figure 8a ). In contrast, FZD7 expression was reduced or undetected in the de-differentiated tumour cells at the tumour invasive front ( Figure 8a ) and in histologically normal colonic epithelium (Figure 8b , 1998) and our thin section electron microscopy studies (data not shown). These combined data from human colorectal cell lines and carcinoma tissues indicated a positive association between FZD7 expression and a well-differentiated epithelial tumour cell phenotype, where FZD7 protein expression in more mesenchymal tumour cells (and normal epithelium) was decreased.
Discussion
CRC can effectively be cured if it remains localized and is surgically resected; however, tumour cells frequently metastasize, mostly to the liver; and metastasis underlies most CRC mortality. Although metastasis rate of poorly differentiated carcinomas is higher, well-differentiated tumours metastasize with high frequency. Therefore, understanding the behavioural transition of well-differentiated epithelial cells in central areas of the tumour mass to the very different phenotype at the invasive front is of fundamental importance to devising strategies to block and eliminate metastasis. Invasion and metastasis are now considered to rely on dynamic reversible processes, which offers more scope for therapeutic intervention. A better understanding of how these dynamic processes (EMT and MET) are coordinated and regulated has important clinical relevance. In addition to identifying prognostic markers, an improved understanding may provide novel avenues to block this rate-limiting step in metastasis. In the current study, we make two contributions to advance current understanding of this dynamic process. Firstly, we have established a unique in vitro model system, LIM1863-Mph that faithfully recapitulates the pathology of the human disease state. Secondly, we provide evidence that FZD7 orchestrates the dynamic transitions between EMT and MET, which implicates FZD7 in CRC morphogenesis. The LIM1863 cell line has many unique features that can be exploited to model CRC in an in vitro setting. The cell line spontaneously forms 3-D spheres or carcinoids that contain several colonic epithelial cell types (Whitehead et al., 1987) . In addition, it has been known for some time that TGFb induces EMT in LIM1863 cells (Hayward et al., 1995) . More recently, Bates and Mercurio (2003) have shown that tumour necrosis factor (TNF) a accelerates TGFb-mediated EMT, and that combined TGFb/TNFa treatment of LIM1863 cells is an excellent model of integrin modulation during CRC metastasis . This cytokine-induced EMT of LIM1863 cells described by Bates et al. (2005) induces complete EMT, as defined by loss of E-cadherin expression. Although some single cells are detected, most of the cells maintain cell-cell contact via intact adherens junctions, despite this loss of E-cadherin (Bates and Mercurio, 2003) . Further analysis revealed that the cells remain in contact because E-cadherin loss is compensated by the expression of another adherens junction protein, N-cadherin (Bates, 2005) . In contrast to this, we found that N-cadherin was not induced by either spontaneous or cytokine-induced EMT in the LIM1863-Mph cells (unpublished data). Notably, Ncadherin is not expressed in CRC patient tissues or CRC cell lines (http://symatlas.gnf.org/SymAtlas/ and our unpublished data). Thus, although the LIM1863 EMT model described by Bates et al. (2005) recapitulates some of the features on CRC metastasis (integrin modulation), it does not mimic the expression pattern of adherens junction proteins nor is it reported to mimic the transient, reversible nature of these phenotype transitions that underscore CRC morphogenesis. CRC tissues have clearly defined invasive areas where the tubular structures of the carcinoma are disorganized yielding tumour cells interspersed with the tumour stroma (Brabletz et al., 2005) . E-cadherin expression is decreased or undetected in tumour cells at the invasive front (Brabletz et al., 2001) , whereas expression of laminin-5 g2 chain (Pyke et al., 1995; Hlubek et al., 2004) , MMP7 (Brabletz et al., 1999) and SNAI2 (Shioiri et al., 2006) is increased. Additionally, cell proliferation (Ki-67 staining) is decreased at the invasive front (Brabletz et al., 2001; Jung et al., 2001) . Consistent with these findings in carcinoma tissues, decreased E-cadherin and cell proliferation, and increased SNAI2, laminin a3 and g2 chains, and MMP7 defined spontaneous EMT of the carcinoids. Thus, different variations of the LIM1863 cell line can model the complete EMT associated with single-cell dissociation from the tumour mass (Bates and Mercurio, 2003; Bates et al., 2005) as well as the initial stages of tubular de-construction (incomplete EMT) and construction (carcinoid assembly) as we show in the current study. Moreover, the LIM1863-Mph cells recapitulate the dynamic nature of these transitions.
Our second finding in this study is that FZD7 is necessary for MET and carcinoid assembly but not for EMT and formation of monolayer patches. RNAimediated depletion of FZD7 in LIM1863-Mph monolayer cells resulted in the persistence of a mesenchymal state, which was paralleled by decreased E-cadherin and cell proliferation, and increased SNAI2. Notably, expression of laminin-5 a3 and g2 chains was dramatically increased by EMT of the carcinoids but was not increased in the FZD7-depleted LIM1863-Mph cells, despite their mesenchymal appearance. However, cell migration was impeded in the FZD7-depleted LIM1863-Mph monolayer cells and as laminin-5 is a basement membrane adhesion protein important for epithelial cell attachment and cell migration (Gilles et al., 2001) , the lack of induction of laminin-5 is consistent with the observed decreased cell migration.
Nuclear localization of b-catenin and canonical Wnt signalling is increased at the invasive front of CRC (reviewed in Kirchner and Brabletz, 2000; Brabletz et al., 2005) . Consistent with this, we recorded increased nuclear localization of b-catenin during EMT of the carcinoid epithelial cells; however, the most dramatic increase in nuclear b-catenin was during MET. This indicates that canonical Wnt signalling was increased during EMT of the polarized carcinoid cells but was transiently further upregulated during subsequent MET of the monolayer cells. This conclusion was corroborated by our observation that carcinoma assembly continues efficiently in the presence of LiCl, an inhibitor of GSK3b that activates canonical Wnt signalling (Kao and Elinson, 1998) . In contrast, carcinoid assembly was inhibited by the EMT-inducing cytokine TGFb. We confirmed that canonical Wnt signalling was constitutively active in the LIM1863-Mph cells, as has been shown for other CRC cell lines (Korinek et al., 1997) , and could be activated further by LiCl. Thus, additional activation of the canonical pathway in LIM1863-Mph monolayer cells promotes MET rather than EMT.
Collectively, these findings with RNAi demonstrate FZD7 functional duality in the context of LIM1863-Mph cells, that is, cell migration and epithelial organization, which may be a reflection of the complexity of this culture system. However, ectopic expression of FZD7 in a simple CRC cell line, the poorly differentiated SW620 cells with low endogenous FZD7, also induced pleiotropic effects (Supplementary Figure 4) . Such functional diversity is in agreement with the roles assigned to FZD7 during embryonic development. Developmental studies show that FZD7 plays a critical role in several morphogenetic events and can orchestrate tissue de-construction (tissue movement/cell migration) as well as tissue construction/organization (epithelialization), depending on the context. During development, FZD7-mediated tissue movement or cell migration involves non-canonical Wnt signalling. For example, neural crest cell migration in birds is mediated by Wnt11/FZD7 (De Calisto et al., 2005) ; and tissue separation (Winklbauer et al., 2001) and convergent extension movements (Djiane et al., 2000) during Xenopus gastrulation are via FZD7-mediated noncanonical Wnt/Ca 2 þ and Wnt/PCP pathways, respectively (reviewed in Kuhl, 2002; Tada et al., 2002) . In contrast, FZD7-mediated tissue construction or epithelialization involves canonical Wnt signalling. Neural crest cell induction, as opposed to neural crest migration, appears to be via Wnt6/FZD7-mediated canonical signalling in birds (Garcia-Castro et al., 2002; BurstynCohen et al., 2004) . Wnt6/FZD7 canonical signalling has also been linked to epithelialization events such as the epithelial organization of somites (Schubert et al., 2002; Schmidt et al., 2004; Linker et al., 2005) . These studies are consistent with the demonstration that canonical Wnt/FZD signalling orchestrates frank MET events such as organogenesis of the mammalian urogenital system (Carroll et al., 2005) . Consistent with these developmental studies, FZD7-mediated canonical signalling was primarily involved in MET and organization of the epithelial cells in the carcinoids. It remains to be determined which Wnt is involved.
FZD7 is overexpressed in diverse human cancers, including CRC (reviewed in Vincan, 2004) ; we confirmed overexpression in CRC and further showed that Nagayama et al., 2005) . Moreover, our observation that FZD7 expression is confined to proliferative areas of carcinomas is in agreement with the recent demonstration that FZD7 mRNA is detected only in the proliferative compartment of both small intestine (Gregorieff et al., 2005; Mariadason et al., 2005) and colonic crypts (Gregorieff et al., 2005) . Given that Wnt and FZD govern morphogenetic developmental processes, we proposed they have a similar tissue-remodelling function in cancer (Vincan, 2004) . More specifically, based on our findings in a 2-D colorectal cell line (Vincan et al., 2005) , we hypothesized that FZD7 promotes the establishment of 3-D tissue architecture. Here, we employed a loss-of-function approach that depends on RNAi-mediated silencing of FZD7 expression in a dynamic 3-D morphogenesis model, the LIM1863-Mph cells, to test our hypothesis. We provide the first evidence that Wnt and FZD (FZD7 in particular) may govern CRC morphogenesis. Thus, in addition to the recognized role of Wnt/FZD signalling in the initiation of CRC (Giles et al., 2003) , our findings implicate active Wnt/FZD signalling in the progression of CRC. A role for the upstream components of the pathway in CRC, despite mutations in down-stream components (e.g. APC), is clearly supported by recent studies that implicate tumour suppressor roles for naturally occurring inhibitors of the pathway, sFRP and DKK (Caldwell et al., 2004; Suzuki et al., 2004; Aguilera et al., 2006) . Importantly, we provide a molecular mechanism for MET in CRC, which we propose is the critical step to metastasis (Brabletz et al., 2001 (Brabletz et al., , 2005 Vincan, 2004) . Moreover, the 3-D model described in this report should facilitate in vitro screening and validation of potential anti-cancer strategies that target MET and tumour morphogenesis. 
Materials and methods
Chemicals and antibodies
Cell lines and culture
Cell lines were either purchased from ATCC (SW480 and SW620) or provided by the Ludwig Institute for Cancer Research, Parkville, Australia (the LIM series) where they were isolated and established. Cells were cultured in RPMI 1640 supplemented with 10% FCS, 20 mM N-2-hydroxyl piperazine-N 0 -2-ethane sulphonic acid and antibiotics (penicillin and streptomycin). LIM1863-Mph cells were cultured in rich medium with additional medium supplements (0.9 mg/ml insulin, 1 mg/ml hydrocortisone, 10 À4 M thioglycerol) and maintained in culture by transferring newly assembled carcinoids to new flasks. All cell lines were regularly tested and confirmed mycoplasma free.
For some experiments (see Results section), monolayer LIM1863-Mph cells were detached with trypsin versine and the cell suspension passed through 40 mm filters to remove any remaining carcinoids. Dissociated cells were seeded in rich medium at less than 2.5 Â 10 4 cells/cm 2 to preferentially form monolayer patches or at 2.5 Â 10 5 cells/cm 2 to preferentially form carcinoids. When the cells were treated with agents, the rich medium was replaced with RPMI supplemented with 5% FCS once the monolayer cell patches were established and the agents added 24 h later. Cells were treated with 2 ng/ml mitomycin C, 100 mg/ml cycloheximide, 10 mM LiCl or 2 mg/ml TGFb1 for 3 days and pulsed with [
3 H]-thymidine during the final 24 h of incubation.
Live cell imaging Cell morphology was recorded using an inverted Olympus microscope (IX81) fitted with a motorized stage and a 371C incubation chamber that is gassed with 5% CO 2 (Solent Scientific, Segensworth, UK). Differential interference contrast (DIC) images were captured using a digital camera (Hamamatsu, Hamamatsu City, Japan) fitted to the microscope and analysed using Metamorph software (Molecular Devices, Chicago, IL, USA). DIC snap-shots were taken hourly over 2-4 days using Metamorph software to drive the motorized stage and digital camera.
Thin section electron microscopy Carcinoids were processed for transmission electron microscopy as described (Whitehead et al., 1987; Thompson et al., 1998) and examined on a Hitachi H600 (Tokyo, Japan) transmission electron microscope.
Confocal immunofluorescence microscopy LIM1863-Mph free-floating carcinoids or monolayer cells, in six-well tissue culture plates, were washed in PBS, fixed in methanol and processed for confocal immunofluorescence microscopy as described (Vincan et al., 2005) . Monolayer cells were immunostained, mounted and analysed in the six-well plates.
Immunohistochemistry and histochemistry
Immunohistochemistry and histochemistry was performed on nine colorectal carcinomas as previously described (Vincan et al., 2005) . In brief, 3 mm sections from formalin-fixed paraffin-embedded, colorectal carcinomas were deparaffinized and rehydrated, and stained with haematoxylin and eosin (HE) following routine protocols, or the sections were immunostained after antigen retrieval by heating in citrate or TRIS/ethylenediaminetetraacetic acid buffer. LIM1863-Mph carcinoids were fixed in methanol and embedded in agarose. The agarose blocks were then formalin-fixed and paraffinembedded for sectioning and processing as for the tissue blocks.
Luciferase reporter assay Monolayer LIM1863-Mph cells established in 24-well plates were co-transfected with 250 ng TOPflash or FOPflash reporter plasmids (Korinek et al., 1997) and 50 ng of the Renilla luciferase reporter phRG-TK (Promega, Madison, WI, USA) using the Fugene transfection reagent (Roche, Indianapolis, IN, USA). The cells were harvested and assayed using the Dual-Luciferase Reporter Assay System as recommended by the manufacturer (Promega).
[
3 H]-thymidine incorporation and crystal violet staining LIM1863-Mph cells in 48-or 6-well plates were pulsed with [ 3 H]-thymidine (Amersham, Little Chalfont, UK) for 20-24 h. The adherent and non-adherent cells were pooled and processed either for b-emission counting (48-well plates) or for six-well plates; half the cells were processed for b-emission counting whereas the remaining cells were resuspended in crystal violet. After 5 min at room temperature, cells were washed free of excess stain, the crystal violet was extracted in methanol and the optical density (OD) was measured at 550 nm as described (Thompson et al., 1993) . Results are expressed as the ratio of cell proliferation (c.p.m.) and cell number (OD 550 ) and are the mean7s.e.m. of at least three independent retroviral infections.
Retrovirus-mediated gene transfer
RNAi targeting sites in the human FZD7 coding sequence (accession number NM_003507) were selected using the siRNA template design tool (Ambion, Austin, TX, USA) and verified by Blast search. Short hairpin (sh) RNA coding oligos were then designed and cloned into the BglII and HindIII sites of the pRETROSUPER vector (generous gift from Reuven Agami, Amsterdam, The Netherlands) as described (Brummelkamp et al., 2002; Eckhardt et al., 2005) . Retroviral plasmids were tested for efficiency of FZD7 mRNA depletion and, of the possible targeting sites that met the Ambion criteria, one shFZD7 targeting sequence (sense oligo, 5 0 -GATCCCCGTACCTGATGACCATGATCTTCAAGAGA GATCATGGTCATCAGGTACTTTTTGGAAA-3 0 ; antisense oligo 5 0 -AGCTTTTCCAAAAAGTACCTGATGACCATGAT CTCTCTTGAAGATCATGGTCATCAGGTACGGG-3 0 ; italics indicate the 9-bp hairpin loop) efficiently depleted endogenous FZD7 mRNA. A similar oligo pair that failed to deplete endogenous FZD7 message, but could deplete FZD7 transcript generated from an expression plasmid (data not shown) was used as control (shCont sense oligo, 5 0 -GATCCCCCAA GTTCGGCTTCCAGTGGTTCAAGAGACCACTGGAAGC CGAACTTGTTTTTGGAAA-3 0 ; antisense oligo 5 0 -AGCTT TTCCAAAAACAAGTTCGGCTTCCAGTGGTCTCTTGAA CCACTGGAAGCCGAACTTGGGG-3 0 ). Retroviral supernatant fluids were prepared as described (Vincan et al., 2005) . Cells were infected with retrovirus in the presence of polybrene (fresh retrovirus aliquot every 12 h for 3 days; plates were centrifuged at 1000 g for 1 h to facilitate infection) and allowed to recover for 24 h before puromycin selection (3-15 mg/ml). LIM1863-Mph cells in replicate wells of six-well plates were puromycin selected for 7-10 days before phenotypic or molecular analysis.
SYBR green real-time RT-PCR
Real-time RT-PCR was performed using the SYBR green PCR master mix and the ABI PRISM 7000 sequence detection system (Applied Biosystems, Foster City, CA, USA) on cDNA synthesized from DNase-treated total RNA as previously described (Vincan et al., 2005) . Briefly, RNA was purified and DNAse treated on Qiagen columns (Promega, Madison, WI, USA), and cDNA synthesized using anchored oligo(dT) 15 Vn primers (GeneWorks, Thebarton, SA, Australia). Gene expression levels were calculated relative to the house-keeping gene hydroxymethyl-bilane synthase (HMBS) (Vandesompele et al., 2002) . Primer sequences are available on request.
